SMPD1 and neoplasm: With promising results from preclinical studies using MRI-guided FUS-MB as a radioenhancer which targets tumour vasculature through the ASMase pathway and ceramide-related endothelial cell apoptosis, we present the first human application of FUS-MB combined with RT in breast malignancies.